fda glp-1 warning news november 2025 Issues Warnings Against Illegal Marketing FDA Approves Orforglipron, First GLP-1

"I think sometimes the individuals making this content mean well, but a lot of the time, they don't realise they're probably doing a disservice to a lot of people and it can be quite dangerous spreading that information," he said

Purchase from vendors with appropriate storage facilities

DOI: 10.1590/s0004-282x1979000100002

Ensure adequate protein intake (generally 0.8-1.0 grams per kilogram of body weight daily per US Dietary Guidelines, though patients with chronic kidney disease should follow their healthcare provider's specific recommendations)

Its safety profile is well-established, with the most common side effects being mild gastrointestinal issues such as nausea, vomiting, and diarrhea